Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Net Income (2018 - 2025)

TransMedics has reported Net Income over the past 8 years, most recently at $18.6 million for Q4 2025.

  • Quarterly results put Net Income at $18.6 million for Q4 2025, up 167.08% from a year ago — trailing twelve months through Dec 2025 was $103.5 million (up 190.92% YoY), and the annual figure for FY2025 was $1.1 million, down 96.87%.
  • Net Income for Q4 2025 was $18.6 million at TransMedics, down from $24.3 million in the prior quarter.
  • Over the last five years, Net Income for TMDX hit a ceiling of $34.9 million in Q2 2025 and a floor of -$25.4 million in Q3 2023.
  • Median Net Income over the past 5 years was $681500.0 (2023), compared with a mean of $3.8 million.
  • Biggest five-year swings in Net Income: tumbled 242.34% in 2023 and later soared 1318.18% in 2024.
  • TransMedics' Net Income stood at $31.7 million in 2021, then tumbled by 122.02% to -$7.0 million in 2022, then surged by 133.91% to $2.4 million in 2023, then surged by 194.29% to $7.0 million in 2024, then skyrocketed by 167.08% to $18.6 million in 2025.
  • The last three reported values for Net Income were $18.6 million (Q4 2025), $24.3 million (Q3 2025), and $34.9 million (Q2 2025) per Business Quant data.